Gamabenzine & Cetrimide Lotion

Gamabenzine (Gamma Benzene Hexachloride) combined with Cetrimide forms a highly effective therapeutic approach within the Dermatology and Anti-Infectives categories. Gamabenzine serves as a potent organochloride parasiticide, while Cetrimide acts as a cationic surfactant and antiseptic agent.

The primary clinical advantage of this combination lies in its comprehensive approach to scabies and pediculosis management. While Gamabenzine aggressively targets the burrowing mites and lice, Cetrimide simultaneously neutralizes the opportunistic bacteria that infect excoriated skin caused by intense scratching. This dual functionality reduces the need for secondary antibiotic prescriptions, accelerating overall patient recovery.

At Saar Biotech, we manufacture Gamabenzine + Cetrimide Lotion using a proprietary controlled shear mixing technique that guarantees unparalleled product stability and dermal safety.

• Uniform Active Dispersion: Both active ingredients are evenly suspended throughout the lotion matrix, ensuring that every milliliter delivers the exact therapeutic dose to the skin without pooling or separation.
• Optimized Dermal pH: The formulation’s pH is meticulously calibrated to match the skin’s natural acid mantle, preventing irritation upon application to compromised or highly sensitive tissues.
• Premium Lotion Base: We utilize a non-greasy, cosmetically elegant vehicle that facilitates effortless full-body application, maximizing patient comfort during the mandatory 8-hour retention period.
• Customizable 100ml Packaging: Recognizing commercial demands, we offer highly tailored packaging solutions—from drip-off embossed cartons to specialized dispensing caps—ensuring your brand stands out in the dermatology segment.

This technical precision guarantees that your third-party brand delivers consistent, reliable eradication of parasitic infestations from the first unit to the last.

Gamabenzine + Cetrimide Lotion is manufactured and supplied by Saar Biotech for the following established clinical indications, making it a critical asset in any dermatology portfolio:

• Scabies Management: Indicated for the eradication of Sarcoptes scabiei mites and their ova. The lotion effectively neutralizes the infestation and prevents secondary purulent complications.
• Pediculosis Treatment: Highly effective against head lice (Pediculus humanus capitis), body lice, and pubic lice (Phthirus pubis).
• Prophylactic Antisepsis: Due to the inclusion of Cetrimide, it serves to cleanse and protect minor excoriations and micro-wounds resulting from severe pruritus, preventing pyoderma.

This formulation requires proper medical guidance regarding application volume and retention time to prevent neurotoxicity.

Clinical Mechanism of Action

The formulation operates through two distinct, synergistic pathways. Gamabenzine (Lindane) is a neurotoxic agent for arthropods. Upon absorption through the parasite’s chitinous exoskeleton, it blocks the GABA-gated chloride channel complex within their central nervous system. This disruption causes cellular hyperexcitability, paralysis, and rapid death of the mites, lice, and their nits.

Simultaneously, Cetrimide functions as a cationic surfactant. It binds to the negatively charged bacterial cell membranes, altering their permeability and causing the leakage of vital intracellular components, culminating in bactericidal action against secondary pathogens.

Manufacturing Integrity

Ensuring the stability of a dual-active topical requires stringent manufacturing oversight:

• Thermal Stability Preservation: Gamabenzine can degrade if subjected to excessive thermal stress during compounding. Saar Biotech employs temperature-controlled blending vessels, ensuring the API is incorporated below critical thermal thresholds to maintain 100% active potency.
• Phase Separation Prevention: The challenge with emulsion-based lotions is maintaining the homogenous distribution of both an organochloride and a quaternary ammonium compound. Our high-shear homogenization protocols create a robust, micro-emulsion network that prevents phase separation or ‘creaming’ throughout the product’s 24-month shelf life.

Saar Biotech provides comprehensive Third-Party Manufacturing and Contract Manufacturing solutions for dermatology products from our dedicated topical facility in Himachal Pradesh.

• Automated Production Lines: Our high-capacity topical manufacturing lines are equipped to handle diverse volume requirements, seamlessly scaling from niche regional launches to massive Pan-India distribution networks.
• Stringent Quality Assurance: In-house GLP-certified laboratories conduct exhaustive rheological and assay testing on every batch, guaranteeing uncompromising compliance with Indian Pharmacopoeia standards.
• Turnaround Efficiency: New private-label orders are executed within 30 to 45 working days following artwork finalization, while subsequent repeat orders are streamlined for delivery within 20 to 25 days.
• B2B Packaging Support: We support our partners with comprehensive design services, offering visually striking mono-cartons and regulatory-compliant labeling that enhances brand credibility.

Proper storage is essential to maintain the lotion’s emulsion stability and therapeutic potency:

1. Warehouse Conditions: Must be stored in a cool, dry environment strictly below 30°C.
2. Thermal Protection: Do not freeze or expose to excessive heat, as extreme temperatures can permanently fracture the emulsion base.
3. Usage Precaution: Formulated exclusively for topical application. The container must be kept tightly closed when not in use to prevent solvent evaporation and contamination.

Every commercial batch is rigorously quarantined and subjected to an exhaustive analytical release protocol before dispatch:

• Quantitative Assay: Simultaneous High-Performance Liquid Chromatography (HPLC) confirms the precise 1% Gamabenzine and 0.1% Cetrimide concentrations.
• Rheological Assessment: Viscosity and spreadability are measured to ensure the lotion meets the exact physical parameters required for comfortable dermal application.
• Microbial Limit Testing (MLT): Comprehensive screening verifies the absolute absence of pathogenic microorganisms.
• Batch Documentation: A detailed Certificate of Analysis (COA) accompanies every B2B shipment, providing complete transparency and supporting our partners’ supply chain integrity.

While highly effective, strict adherence to safety protocols is mandatory:

• Dermal Application Only: Strictly for external use. Avoid application to face, eyes, mucous membranes, or acutely inflamed skin.
• Toxicity Warning: Over-application or prolonged retention beyond 12 hours increases the risk of systemic absorption, which can precipitate neurotoxic events (including seizures).
• Contraindicated Demographics: Use is generally contraindicated in premature infants, patients with uncontrolled seizure disorders, and individuals weighing less than 50 kg unless specifically directed by a specialist.
• Pregnancy & Lactation: Should only be prescribed when the potential benefit strictly outweighs the documented risks.